Mir Imran is a prolific healthcare innovator and entrepreneur who has been developing and commercializing breakthrough medical innovations for more than 30 years. Since 1995, Mir's innovations, including Rani Therapeutics, have been developed at his life science R&D lab and incubator, InCube Labs. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen "liquidity events" (IPO/Acquisition). Mir now holds more than 300 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. In addition to leading Rani Therapeutics and InCube Labs, Mir also runs a life sciences venture fund, InCube Ventures; VentureHealth, a healthcare crowd funding portal; and Modulus, a medical manufacturing company. Mir has received a number of industry accolades for his work including being named one of the "Top 50 Medical Device Inventors of All Time" by QMed and recognized as a National Academy of Inventors (NAI) fellow in 2015. He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. Mir also attended CMDNJ/Rutgers Medical School.